Login to Your Account



UK Bioscience Gets $62M to Bridge Valley of Death

By Cormac Sheridan
Staff Writer

Wednesday, November 7, 2012
Twenty-two UK life sciences companies and a further 10 academic groups will share £39 million (US$62.3 million) in research funding in the largest grant allocation that the Biomedical Catalyst scheme has made to date.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription